Two of AcouSort’s board members and CEO acquire shares

AcouSort AB (publ) (“AcouSort” or the “Company”) today announces that founders and board members Thomas Laurell and Stefan Scheding as well as CEO Torsten Freltoft have acquired shares in the Company at a value of approximately SEK 150,000. The transactions took place on 1 and 2 December 2022.

“My acquisition of shares in AcouSort should be seen in the light of the positive development that the Company is in. We are currently working intensively to commercialize our current product portfolio and we recently completed the highly successful BioWings project. We are now bringing BioWings’ technological advances into our next major development project AcouSome, where the ambition is to develop a groundbreaking technology for exosome-based diagnostics. Both projects have received significant research funding from the EU. I would also like to mention that the price for the shares that I and board members Thomas Laurell and Stefan Scheeding have acquired corresponds to the exercise price for our warrants in the current option program,” says CEO Torsten Freltoft in a comment.

For detailed information, please refer to the Swedish Financial Supervisory Authority’s website (https://marknadssok.fi.se/publiceringsklient) for insider trading.